-
公开(公告)号：US09908933B2
公开(公告)日：2018-03-06
申请号：US14910172
申请日：2014-08-05
IPC分类号： C07K16/18 , A61K39/395 , G01N33/53 , C07H21/04 , G01N33/68
CPC分类号： C07K16/18 , C07K2299/00 , C07K2317/24 , C07K2317/33 , C07K2317/34 , C07K2317/55 , C07K2317/565 , C07K2317/76 , G01N33/689 , G01N33/6896 , G01N2333/4709 , G01N2800/2821 , G01N2800/368
摘要： The present disclosure relates generally to a protocol to treat or prevent diseases or conditions associated with pathological forms of amyloid beta (Aβ), including Alzheimer's disease. Enabled herein is a reagent for use in the treatment and prophylaxis of Aβ-associated pathological conditions.
-
公开(公告)号：US20160194385A1
公开(公告)日：2016-07-07
申请号：US14910172
申请日：2014-08-05
CPC分类号： C07K16/18 , C07K2299/00 , C07K2317/24 , C07K2317/33 , C07K2317/34 , C07K2317/55 , C07K2317/565 , C07K2317/76 , G01N33/689 , G01N33/6896 , G01N2333/4709 , G01N2800/2821 , G01N2800/368
摘要： The present disclosure relates generally to a protocol to treat or prevent diseases or conditions associated with pathological forms of amyloid beta (Aβ), including Alzheimer's disease. Enabled herein is a reagent for use in the treatment and prophylaxis of Aβ-associated pathological conditions.
摘要翻译： 本公开一般涉及治疗或预防与淀粉样蛋白β（A＆bgr）的病理形式（包括阿尔茨海默氏病）相关的疾病或病症的方案。 本文使用的是用于治疗和预防与疾病相关的病理状况的试剂。
-
公开(公告)号：US20180148499A1
公开(公告)日：2018-05-31
申请号：US15875082
申请日：2018-01-19
CPC分类号： C07K16/18 , C07K2299/00 , C07K2317/24 , C07K2317/33 , C07K2317/34 , C07K2317/55 , C07K2317/565 , C07K2317/76 , G01N33/689 , G01N33/6896 , G01N2333/4709 , G01N2800/2821 , G01N2800/368
摘要： The present disclosure relates generally to a protocol to treat or prevent diseases or conditions associated with pathological forms of amyloid beta (Aβ), including Alzheimer's disease. Enabled herein is a reagent for use in the treatment and prophylaxis of Aβ-associated pathological conditions.
-
-
搜索结果
3 条记录 (耗时 0.016 秒)
